The dose schedule for MenACWY vaccine depends on the vaccine brand and the person’s age when they start the vaccine course.
Aboriginal and Torres Strait Islander infants and children with specified medical risk conditions are recommended to receive an additional dose of MenACWY vaccine, see People with medical conditions that increase their risk of invasive meningococcal disease.
Infants aged <12 months can receive 2 of the 3 brands of MenACWY vaccine (Menveo or Nimenrix).
There is no preference for either brand of MenACWY vaccine – MenQuadfi, Menveo, or Nimenrix – for people aged ≥12 months.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.